BCL2 and neoplasm: Over-expression of PBXIP1 (HPIP) has been shown to inhibit apoptosis by up-regulating BCL2, to promote tumor cell proliferation via activation of ER, and to mediate EMT by regulating mesenchymal genes such as N-cadherin and Vimentin (22).